132 related articles for article (PubMed ID: 35012903)
21. Late postpancreatectomy hemorrhage after pancreaticoduodenectomy: is it possible to recognize risk factors?
Ricci C; Casadei R; Buscemi S; Minni F
JOP; 2012 Mar; 13(2):193-8. PubMed ID: 22406600
[TBL] [Abstract][Full Text] [Related]
22. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by the resectability status.
Kondo N; Murakami Y; Uemura K; Nakagawa N; Okada K; Takahashi S; Sueda T
J Surg Oncol; 2018 Dec; 118(7):1105-1114. PubMed ID: 29878355
[TBL] [Abstract][Full Text] [Related]
24. Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma.
Nassour I; Winters SB; Hoehn R; Tohme S; Adam MA; Bartlett DL; Lee KK; Paniccia A; Zureikat AH
J Surg Oncol; 2020 Aug; 122(2):234-242. PubMed ID: 32350882
[TBL] [Abstract][Full Text] [Related]
25. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
26. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection.
Shirai Y; Shiba H; Sakamoto T; Horiuchi T; Haruki K; Fujiwara Y; Futagawa Y; Ohashi T; Yanaga K
Surgery; 2015 Aug; 158(2):360-5. PubMed ID: 26032829
[TBL] [Abstract][Full Text] [Related]
27. Comparing Post-Operative Outcomes of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: Neoadjuvant Therapy Versus Surgery First Approach.
Hyman DW; Almerey T; Mujkanovic A; Hammons I; Tice M; Stauffer JA
Am Surg; 2022 Aug; 88(8):1868-1874. PubMed ID: 35465681
[TBL] [Abstract][Full Text] [Related]
28. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
[TBL] [Abstract][Full Text] [Related]
29. Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.
Feo CF; Deiana G; Ninniri C; Cherchi G; Crivelli P; Fancellu A; Ginesu GC; Porcu A
World J Surg Oncol; 2021 Apr; 19(1):126. PubMed ID: 33866970
[TBL] [Abstract][Full Text] [Related]
30. Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study.
Nakano Y; Kitago M; Shinoda M; Abe Y; Yagi H; Hibi T; Takeuchi A; Aiura K; Itano O; Kitagawa Y
Cancer Med; 2017 Oct; 6(10):2278-2286. PubMed ID: 28925039
[TBL] [Abstract][Full Text] [Related]
31. Effect of body fat mass loss on prognosis of radical resection for pancreatic ductal adenocarcinoma based on bioelectrical impedance analysis.
Shibata Y; Sudo T; Tazuma S; Sada H; Tanimine N; Shimada N; Tazawa H; Suzuki T; Onoe T; Shimizu Y; Tashiro H; Yamaguchi A; Takahashi S
BMC Surg; 2024 Jan; 24(1):19. PubMed ID: 38212728
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of preoperative risk factors for postpancreatectomy hemorrhage.
Izumo W; Higuchi R; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Langenbecks Arch Surg; 2019 Dec; 404(8):967-974. PubMed ID: 31650216
[TBL] [Abstract][Full Text] [Related]
33. The role of coeliac axis resection in resected ductal adenocarcinoma of the distal pancreas: A result of tumour topography or a prognostic factor?
Liu B; Wu J; Li C; Li Y; Qiu H; Lv A; Liu Q; Liu D; Wang Z; Hao C
Pancreatology; 2022 Jan; 22(1):112-122. PubMed ID: 34764022
[TBL] [Abstract][Full Text] [Related]
34. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.
Matsumoto I; Murakami Y; Shinzeki M; Asari S; Goto T; Tani M; Motoi F; Uemura K; Sho M; Satoi S; Honda G; Yamaue H; Unno M; Akahori T; Kwon AH; Kurata M; Ajiki T; Fukumoto T; Ku Y
Pancreatology; 2015; 15(6):674-80. PubMed ID: 26467797
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center experience.
Zhang AB; Wang Y; Hu C; Shen Y; Zheng SS
J Zhejiang Univ Sci B; 2017 Jun; 18(6):532-538. PubMed ID: 28585429
[TBL] [Abstract][Full Text] [Related]
36. Impact of Changes in the American Joint Committee on Cancer Staging Manual, Eighth Edition, for Pancreatic Ductal Adenocarcinoma.
Kassardjian A; Stanzione N; Donahue TR; Wainberg ZA; Damato L; Wang HL
Pancreas; 2019 Aug; 48(7):876-882. PubMed ID: 31268985
[TBL] [Abstract][Full Text] [Related]
37. Comparison of clinical outcomes and prognosis between total pancreatectomy and pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
Hong S; Ren J; Zhang S; Yan Y; Liu S; Qi F
ANZ J Surg; 2023 Dec; 93(12):2820-2827. PubMed ID: 37614050
[TBL] [Abstract][Full Text] [Related]
38. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
39. LDP vs ODP for pancreatic adenocarcinoma: a case matched study from a single-institution.
Zhang M; Fang R; Mou Y; Chen R; Xu X; Zhang R; Yan J; Jin W; Ajoodhea H
BMC Gastroenterol; 2015 Dec; 15():182. PubMed ID: 26695506
[TBL] [Abstract][Full Text] [Related]
40. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
